IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Great Point Partners LLC

Q3 2018 Holdings

Filed 2018-11-14 | 30 holdings | $143.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biocryst Pharmaceuticals(BCRX)COM09058V103$60.9M7,978,27542.4%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$26.3M300,00018.3%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$24.8M1,196,09817.3%
Cytokinetics Inc(CYTK)COM23282W605$21.5M2,179,68814.9%
Argenx SE(ARGX)SPONSORED ADR04016X101$9.8M129,0606.8%
Acceleron Pharma Inc(XLRN)COM00434H108$52.5K917,7670.0%
Zafgen IncCOM98885E103$39.6K3,391,3850.0%
Iovance Biotherapeutics Inc(IOVA)COM462260100$39.3K3,496,3400.0%
United Therapeutics Corp del(UTHR)COM91307C102$38.4K300,0000.0%
Kura Oncology Inc(KURA)COM50127T109$37.1K2,119,1060.0%
Exelixis Inc(EXEL)COM30161Q104$36.8K2,075,0000.0%
PTC Therapeutics Inc(PTCT)COM69366J200$33.7K717,4580.0%
Endocyte IncCOM29269A102$28.5K1,606,1000.0%
Voyager Therapeutics Inc(VYGR)COM92915B106$26.5K1,400,0000.0%
Savara Inc(SVRA)COM805111101$25.0K2,243,0840.0%
Foamix Pharmaceuticals LTDSHSM46135105$23.1K4,030,2680.0%
Five Prime Therapeutics Inc(FPRX)COM33830X104$22.9K1,647,7530.0%
Spark Therapeutics IncCOM84652J103$21.4K393,1470.0%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$18.0K210,4000.0%
Menlo Therapeutics IncCOM586858102$12.8K1,304,4070.0%
TG Therapeutics Inc(TGTX)COM88322Q108$10.9K1,950,0000.0%
Protagonist Therapeutics Inc(PTGX)COM74366E102$10.1K982,4490.0%
Madrigal Pharmaceuticals Inc(MDGL)COM558868105$8.7K40,4000.0%
Intra Cellular Therapies Inc(ITCIEUR)PutCOM46116X101$4.3K200,0000.0%
Zymeworks IncCOM98985W102$3.8K241,9700.0%
Sunesis Pharmaceuticals IncCOM867328700$2.0K1,000,0000.0%
Acer Therapeutics Inc(OPXAEUR)COM00444P108$1.8K58,4610.0%
Sierra Oncology IncCOM82640U107$834490,8430.0%
Streamline Health SolutionsCOM86323X106$153130,1370.0%
CTI Biopharma Corp(CTIC1USD)COM12648L601$4621,4410.0%